1.15 USD
-0.48 (-29.45%)
1.12 USD
-0.03 (-2.61%)
Taking everything into account, MNDR scores 2 out of 10 in our fundamental rating. MNDR was compared to 102 industry peers in the Health Care Providers & Services industry. The financial health of MNDR is average, but there are quite some concerns on its profitability. MNDR does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- MNDR had negative earnings in the past year.
- MNDR had a negative operating cash flow in the past year.
- In the past 5 years MNDR reported 4 times negative net income.
- MNDR had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- MNDR has a Return On Assets of -113.31%. This is amonst the worse of the industry: MNDR underperforms 92.16% of its industry peers.
- MNDR's Return On Equity of -192.59% is on the low side compared to the rest of the industry. MNDR is outperformed by 76.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -113.31% | ||
| ROE | -192.59% | ||
| ROIC | N/A |
ROA(3y)-121.89%
ROA(5y)-86.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- MNDR has a worse Gross Margin (16.06%) than 62.75% of its industry peers.
- In the last couple of years the Gross Margin of MNDR has declined.
- MNDR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.44%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- MNDR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- MNDR has less shares outstanding than it did 1 year ago.
- There is no outstanding debt for MNDR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -9.10, we must say that MNDR is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of -9.10, MNDR is not doing good in the industry: 90.20% of the companies in the same industry are doing better.
- There is no outstanding debt for MNDR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -9.1 |
ROIC/WACCN/A
WACC8.9%
2.3 Liquidity
- MNDR has a Current Ratio of 1.06. This is a normal value and indicates that MNDR is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.06, MNDR is doing worse than 65.69% of the companies in the same industry.
- MNDR has a Quick Ratio of 1.06. This is a bad value and indicates that MNDR is not financially healthy enough and could expect problems in meeting its short term obligations.
- MNDR has a worse Quick ratio (0.99) than 65.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
- The earnings per share for MNDR have decreased strongly by -303.19% in the last year.
- MNDR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -42.16%.
- MNDR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)-303.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-325.52%
Revenue 1Y (TTM)-42.16%
Revenue growth 3Y3.04%
Revenue growth 5YN/A
Sales Q2Q%-45.26%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y150%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year76.44%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for MNDR. In the last year negative earnings were reported.
- A Price/Forward Earnings ratio of 56.37 indicates a quite expensive valuation of MNDR.
- MNDR's Price/Forward Earnings ratio is in line with the industry average.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, MNDR is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 56.37 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- MNDR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- MNDR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MOBILE-HEALTH NETWORK SOLUTI / MNDR FAQ
What is the ChartMill fundamental rating of MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?
ChartMill assigns a fundamental rating of 2 / 10 to MNDR.
What is the valuation status for MNDR stock?
ChartMill assigns a valuation rating of 1 / 10 to MOBILE-HEALTH NETWORK SOLUTI (MNDR). This can be considered as Overvalued.
How profitable is MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?
MOBILE-HEALTH NETWORK SOLUTI (MNDR) has a profitability rating of 0 / 10.
How financially healthy is MOBILE-HEALTH NETWORK SOLUTI?
The financial health rating of MOBILE-HEALTH NETWORK SOLUTI (MNDR) is 5 / 10.